[{"AccountsPayableCurrent_0_Q2_USD":9233000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_2_Q2_USD":564000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q2_USD":370149000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":10897000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":24902000.0,"AccountsReceivableGross_0_Q2_USD":28501000.0,"AccruedPayrollTaxesCurrent_0_Q2_USD":7765000.0,"ProceedsFromIssuanceOfDebt_2_Q2_USD":287500000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q2_USD":-605000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":5489000.0,"AccruedBonusesCurrent_0_Q2_USD":7320000.0,"AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_1_Q2_USD":81554000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":13062000.0,"AllowanceForLoanAndLeaseLossesWriteOffs_2_Q2_USD":0.0,"AmortizationOfFinancingCostsAndDiscounts_2_Q2_USD":557000.0,"AssetsFairValueDisclosure_0_Q2_USD":317092000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q2_USD":980000.0,"DeferredCompensationLiabilityClassifiedNoncurrent_0_Q2_USD":4100000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_2_Q2_USD":45011000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":276300000.0,"TreasuryStockValue_0_Q2_USD":132000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0_Q2_USD":24912000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0_Q2_USD":24912000.0,"Goodwill_0_Q2_USD":66134000.0,"NonoperatingIncomeExpense_1_Q2_USD":-81000.0,"NonoperatingIncomeExpense_2_Q2_USD":-1977000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":18513000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":943706000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-39446000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-92815000.0,"OtherComprehensiveIncomeLossNetOfTax_2_Q2_USD":1137000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q2_USD":448000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":14644000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":6590000.0,"AccountsReceivableNet_0_Q2_USD":26730000.0,"FinanceLeaseLiabilityNoncurrent_0_Q2_USD":60435000.0,"GainLossOnSaleOfPropertyPlantEquipment_2_Q2_USD":-15000.0,"TreasuryStockShares_0_Q2_shares":28000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q2_USD":15000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0_Q2_USD":24912000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q2_USD":127001000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":204544000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":14328000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_1_Q2_USD":1053000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_2_Q2_USD":573000.0,"PaymentsForRestructuring_2_Q2_USD":4085000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_2_Q2_USD":2013000.0,"PaymentsToAcquireMarketableSecurities_2_Q2_USD":60883000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_2_Q2_USD":1278000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":13305000.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_1_Q2_USD":18971000.0,"RestrictedCash_0_Q2_USD":9326000.0,"RestrictedCashAndCashEquivalentsNoncurrent_0_Q2_USD":9326000.0,"RestructuringAndRelatedCostExpectedCost1_0_Q2_USD":5300000.0,"RestructuringCharges_2_Q2_USD":796000.0,"RestructuringReserve_0_Q2_USD":807000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":31558000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":86894000.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_2_Q2_USD":43844000.0,"OperatingLeaseLiability_0_Q2_USD":15335000.0,"NumberOfOperatingSegments_2_Q2_segment":1.0,"LettersOfCreditOutstandingAmount_0_Q2_USD":8800000.0,"DeferredCompensationPlanAssets_0_Q2_USD":4200000.0,"FinanceLeaseLiability_0_Q2_USD":60210000.0,"FinanceLeaseLiabilityPaymentsDue_0_Q2_USD":127088000.0,"FinanceLeaseLiabilityPaymentsDueYearFive_0_Q2_USD":5184000.0,"FinanceLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":3543000.0,"FinanceLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":66878000.0,"FinanceLeaseRightOfUseAsset_0_Q2_USD":52833000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_0_Q2_USD":12456000.0,"IncreaseDecreaseInOtherNoncurrentAssets_2_Q2_USD":211000.0,"InventoryWriteDown_2_Q2_USD":7400000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":18376000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFive_0_Q2_USD":2023000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":2230000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":3123000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":3197000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":1527000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":3041000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q2_USD":127966000.0,"StockIssuedDuringPeriodValueShareBasedCompensationGross_1_Q2_USD":1634000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_0_Q2_USD":24619000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0_Q2_USD":62900000.0,"Liabilities_0_Q2_USD":333309000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":995733000.0,"LiabilitiesCurrent_0_Q2_USD":54831000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":248062000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-20039000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-24022000.0,"NetIncomeLoss_1_Q2_USD":-39894000.0,"InventoryNet_0_Q2_USD":21088000.0,"NetIncomeLoss_2_Q2_USD":-93952000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":10464000.0,"ProfitLoss_1_Q2_USD":-39894000.0,"ProfitLoss_2_Q2_USD":-93952000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":23210000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-283662000.0,"StockholdersEquity_0_Q2_USD":662424000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":44335000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":3509000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":-11556000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":-7834000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":-7384000.0,"AccountsReceivableNetCurrent_0_Q2_USD":26730000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":2467000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q2_shares":5852000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":5078000.0,"Assets_0_Q2_USD":995733000.0,"AssetsCurrent_0_Q2_USD":453222000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":266974000.0,"CommonStockSharesIssued_0_Q2_shares":44578000.0,"CommonStockSharesOutstanding_0_Q2_shares":44550000.0,"CommonStockValue_0_Q2_USD":45000.0,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.9,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-2.13,"EffectOfExchangeRateOnCashAndCashEquivalents_2_Q2_USD":543000.0,"GrossProfit_1_Q2_USD":9890000.0,"GrossProfit_2_Q2_USD":32697000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":-47278000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":-101786000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":44078000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_0_Q2_USD":139438000.0,"AccruedLiabilitiesCurrent_0_Q2_USD":45598000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"EffectiveIncomeTaxRateContinuingOperations_1_Q2_pure":0.156,"EffectiveIncomeTaxRateContinuingOperations_2_Q2_pure":0.077,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2_Q2_USD":1998000.0,"IncreaseDecreaseInInventories_2_Q2_USD":-21396000.0,"InterestAndOtherIncome_1_Q2_USD":590000.0,"InterestAndOtherIncome_2_Q2_USD":1286000.0,"InventoryFinishedGoods_0_Q2_USD":8328000.0,"DeferredIncomeTaxLiabilitiesNet_0_Q2_USD":15250000.0,"InventoryGross_0_Q2_USD":21088000.0,"InventoryWorkInProcess_0_Q2_USD":3471000.0,"AccruedProfessionalFeesCurrent_0_Q2_USD":5547000.0,"FiniteLivedIntangibleAssetsGross_0_Q2_USD":266300000.0,"FiniteLivedIntangibleAssetsNet_0_Q2_USD":251249000.0,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q2_USD":662424000.0,"CostOfGoodsAndServicesSold_1_Q2_USD":21668000.0,"CostOfGoodsAndServicesSold_2_Q2_USD":54197000.0,"InventoryRawMaterials_0_Q2_USD":9289000.0,"AccruedVacationCurrent_0_Q2_USD":3369000.0,"ShareBasedCompensation_2_Q2_USD":28073000.0,"SellingGeneralAndAdministrativeExpense_2_Q2_USD":88662000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.001,"CommonStockSharesAuthorized_0_Q2_shares":150000000.0,"ConvertibleLongTermNotesPayable_0_Q2_USD":183999000.0,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q2_USD":15051000.0,"IncomeTaxesPaidNet_2_Q2_USD":294000.0,"IntangibleAssetsNetIncludingGoodwill_0_Q2_USD":436283000.0,"OperatingExpenses_1_Q2_USD":57087000.0,"OperatingExpenses_2_Q2_USD":132506000.0,"OperatingIncomeLoss_1_Q2_USD":-47197000.0,"OperatingIncomeLoss_2_Q2_USD":-99809000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.001,"PreferredStockSharesAuthorized_0_Q2_shares":5000000.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"PreferredStockValue_0_Q2_USD":null,"ProceedsFromConvertibleDebt_2_Q2_USD":-9614000.0,"SellingGeneralAndAdministrativeExpense_1_Q2_USD":38116000.0,"AllowanceForDoubtfulAccountsReceivable_0_Q2_USD":1771000.0,"UnrecognizedTaxBenefits_0_Q2_USD":18700000.0,"Ticker":"GKOS","CIK":"1192448","name":"GLAUKOS CORP","OfficialName":"Glaukos Corporation Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"2869781865.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Electromedical & Electrotherapeutic Apparatus","Market":"NYSE","SP500":"nan","filed":"20200810"}]